CTKB 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-08-05

• and $24.8 million for the three and six months ended June 30, 2026, respectively, and $12.1 million and $24.6 million for the three and six months ended June 30, 2025, respectively.

• Biotechnology, pharmaceutical, distributor and contract research organizations

• Since 2025, the U.S. government has made and continues to signal additional changes to existing U.S. trade policies, including imposing and announcing plans for tariffs on all U.S. trading partners, including China, and renegotiating or

• potentially terminating existing bilateral and multi-lateral trade agreements. In February 2026, the U.S. Supreme Court issued a ruling invalidating certain tariffs previously imposed by the U.S. government under the International Emergency Economic Powers Act (“IEEPA”); following this ruling, we ap…

• Gross profit is calculated as revenue less total cost of sales. Gross margin is gross profit expressed as a percentage of revenue. Our gross profit in future periods will depend on a variety of factors, including market conditions that may impact

相对上期删除的文字 · 来源:10-Q · 2026-05-07

• partners. We plan to continue to invest in new product development and enhancements to support our expansion into new markets.

• Biotechnology, pharmaceutical, distributor and CRO27,196 24,325 2,871

• The U.S. government has made and continues to signal additional changes to existing U.S. trade policies, including imposing and announcing plans for tariffs on all U.S. trading partners, including China, and renegotiating or potentially terminating existing bilateral and multi-lateral trade agreemen…

• threatened and actual retaliatory tariffs against U.S. goods may have a negative impact on our revenue and costs in the future.

• In February 2026, the U.S. Supreme Court issued a ruling invalidating certain tariffs previously imposed under the International Emergency Economic Powers Act (“IEEPA”). The Company is currently evaluating whether it may be entitled to refunds related to these tariffs. As of March 31, 2026, the Comp…

相对上期新增的文字 · 来源:10-Q · 2026-08-05

• immediately follows this risk factor summary. The below risk factor summary is qualified in its entirety by that more complete discussion of such risks and uncertainties.

• •If our information technology systems or data, or those of third parties with whom we work, are compromised, now or in the future, we could experience adverse consequences resulting from such a compromise, including but not limited to regulatory investigations or actions; litigation; fines and pena…

• •Our executive officers, directors, and principal stockholders and their respective affiliates, if they choose to act together, have the ability to significantly influence all matters submitted to stockholders for approval.

• or if we do not address these risks successfully, our results of operations could differ materially from our expectations, and our business, financial condition and results of operations could be materially and adversely affected.

• past and may in the future become subject to trade restrictions, sanctions, other regulatory requirements, or proposed legislation by the U.S. government, which could restrict or even prohibit our ability to work with such entities, thereby potentially disrupting the supply of material to our Wuxi f…

相对上期删除的文字 · 来源:10-Q · 2026-05-07

• •If our information technology systems or data, or those of third parties with whom we work, are compromised, now or in the future, we could experience adverse consequences resulting from such a

• compromise, including but not limited to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; loss of customers or sales; and other adverse consequences.

• •Concentration of ownership of our common stock among our executive officers, directors, and principal stockholders and their respective affiliates may prevent new investors from influencing significant corporate decisions.

• Trade disputes, tariffs, restrictions and other political tensions between the United States and other countries may also exacerbate unfavorable macroeconomic conditions, including inflationary pressures, foreign exchange volatility, financial market instability, and economic recessions or downturns…

• prospects. While we actively monitor these risks, any prolonged economic downturn, escalation in trade tensions, or deterioration in international perception of U.S.-based companies could materially and adversely affect our business, ability to access the capital markets or other financing sources, …